Search Results - "Heresi, Gustavo"

Refine Results
  1. 1

    Impact of Multidisciplinary Pulmonary Embolism Response Team Availability on Management and Outcomes by Chaudhury, Pulkit, Gadre, Shruti Kumar, Schneider, Erika, Renapurkar, Rahul D., Gomes, Marcelo, Haddadin, Ihab, Heresi, Gustavo A., Tong, Michael Z., Bartholomew, John R.

    Published in The American journal of cardiology (01-11-2019)
    “…Treatment strategies for complex patients with pulmonary embolism (PE) are often debated given patient heterogeneity, multitude of available treatment…”
    Get full text
    Journal Article
  2. 2

    Off-Label Use and Inappropriate Dosing of Direct Oral Anticoagulants in Cardiopulmonary Disease by Hussein, Ayman A., Alvarez, Paulino, Reed, Grant, Heresi, Gustavo A.

    Published in Chest (01-05-2022)
    “…Direct oral anticoagulants (DOACs) are increasingly used in clinical practice and have become essential in the management of atrial fibrillation and VTE. The…”
    Get full text
    Journal Article
  3. 3

    Follow-Up Functional Class and 6-Minute Walk Distance Identify Long-Term Survival in Pulmonary Arterial Hypertension by Heresi, Gustavo A., Rao, Youlan

    Published in Lung (01-12-2020)
    “…Purpose Guidelines recommend specific treatment goals for pulmonary arterial hypertension (PAH) patients: functional class I or II, 6-min walk distance (6MWD)…”
    Get full text
    Journal Article
  4. 4

    Plasma levels of high density lipoprotein cholesterol and outcomes in chronic thromboembolic pulmonary hypertension by Khirfan, Ghaleb, Tejwani, Vickram, Wang, Xiaofeng, Li, Manshi, DiDonato, Joseph, Dweik, Raed A, Smedira, Nicholas, Heresi, Gustavo A

    Published in PloS one (29-05-2018)
    “…High Density Lipoprotein Cholesterol (HDL-C) has various anti-inflammatory, anti-atherogenic, anti-oxidant and anti-coagulant properties that improve vascular…”
    Get full text
    Journal Article
  5. 5

    Causes and Circumstances of Death in Pulmonary Arterial Hypertension by TONELLI, Adriano R, ARELLI, Vineesha, MINAI, Omar A, NEWMAN, Jennie, BAIR, Nancy, HERESI, Gustavo A, DWEIK, Raed A

    “…The causes and circumstances surrounding death are understudied in patients with pulmonary arterial hypertension (PAH). We sought to determine the specific…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Lessons learned in developing a chronic thromboembolic pulmonary hypertension program by Bair, Nancy D., Heresi, Gustavo A.

    Published in Current opinion in pulmonary medicine (01-09-2023)
    “…Chronic thromboembolic pulmonary hypertension (CTEPH) is a deadly underdiagnosed form of pulmonary hypertension, traditionally treated with surgical extraction…”
    Get full text
    Journal Article
  8. 8

    COVID-19 and Pulmonary Arterial Hypertension: Early Data and Many Questions by Farha, Samar, Heresi, Gustavo A

    Published in Annals of the American Thoracic Society (01-12-2020)
    “…Farha and Heresi express insights about COVID-19 and pulmonary arterial hypertension. Coronavirus disease (COVID-19), first described in Wuhan, China, in…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Mixed Venous Oxygen Saturation Is a Better Prognosticator Than Cardiac Index in Pulmonary Arterial Hypertension by Khirfan, Ghaleb, Almoushref, Allaa, Naal, Tawfeq, Abuhalimeh, Batool, Dweik, Raed A., Heresi, Gustavo A., Tonelli, Adriano R.

    Published in Chest (01-12-2020)
    “…European Society of Cardiology (ESC) and European Respiratory Society (ERS) guidelines include thermodilution cardiac index (TDCI) and mixed venous oxygen…”
    Get full text
    Journal Article
  11. 11

    Hypoxemia in patients with idiopathic or heritable pulmonary arterial hypertension by Khirfan, Ghaleb, Naal, Tawfeq, Abuhalimeh, Batool, Newman, Jennie, Heresi, Gustavo A, Dweik, Raed A, Tonelli, Adriano R

    Published in PloS one (01-01-2018)
    “…The prevalence and prognostic implications of hypoxemia either at rest or during six-minute walk test (6MWT) in patients with idiopathic or heritable pulmonary…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15

    Morphologic and Functional Dual-Energy CT Parameters in Patients With Chronic Thromboembolic Pulmonary Hypertension and Chronic Thromboembolic Disease by Saeedan, Mnahi Bin, Bullen, Jennifer, Heresi, Gustavo A, Rizk, Alain, Karim, Wadih, Renapurkar, Rahul D

    Published in American journal of roentgenology (1976) (01-12-2020)
    “…The objective of our study was to compare morphologic and functional dual-energy CT (DECT) parameters in patients with chronic thromboembolic disease (CTED)…”
    Get full text
    Journal Article
  16. 16

    Lipids and ketones dominate metabolism at the expense of glucose control in pulmonary arterial hypertension: a hyperglycaemic clamp and metabolomics study by Mey, Jacob T, Hari, Adithya, Axelrod, Christopher L, Fealy, Ciarán E, Erickson, Melissa L, Kirwan, John P, Dweik, Raed A, Heresi, Gustavo A

    Published in The European respiratory journal (01-04-2020)
    “…Individuals with idiopathic pulmonary arterial hypertension (PAH) display reduced oral glucose tolerance. This may involve defects in pancreatic function or…”
    Get full text
    Journal Article
  17. 17

    Plasma levels of high-density lipoprotein cholesterol and outcomes in pulmonary arterial hypertension by Heresi, Gustavo A, Aytekin, Metin, Newman, Jennie, DiDonato, Joseph, Dweik, Raed A

    “…High-density lipoprotein cholesterol (HDL-C) promotes healthy vascular function, and it is decreased in insulin resistance. Insulin resistance predisposes to…”
    Get full text
    Journal Article
  18. 18

    Is pulmonary vascular resistance index better than pulmonary vascular resistance in predicting outcomes in pulmonary arterial hypertension? by Khirfan, Ghaleb, Li, Manshi, Wang, Xiaofeng, Dweik, Raed A., Heresi, Gustavo A., Tonelli, Adriano R.

    “…In contrast to pulmonary vascular resistance (PVR), PVR index (PVRI) accounts for variations in body habitus. We tested the association of PVRI compared to PVR…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Predictors of survival in portopulmonary hypertension: a 20-year experience by Aggarwal, Manik, Li, Manshi, Bhardwaj, Abhishek, Wallace, William D., Wang, Xiaofeng, Carey, William D., Dweik, Raed A., Heresi, Gustavo A., Tonelli, Adriano R.

    “…Portopulmonary hypertension (PoPH) is a rare complication of portal hypertension associated with poor survival. Scarce data is available on predictors of…”
    Get full text
    Journal Article